Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alastair Kent

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Science Translational Medicine|July 7, 2017
Marketing of unproven stem cell-based interventions: A call to actionDouglas Sipp, Timothy Caulfield, Jane Kaye, et al.
European Journal of Human Genetics : EJHG|January 16, 2014
Managing clinically significant findings in research: the UK10K exampleJane Kaye, Matthew Hurles, Heather Griffin, et al.
Biomedicine Hub|February 10, 2021
Time for Change? The Why, What and How of Promoting Innovation to Tackle Rare Diseases - Is It Time to Update the EU's Orphan Regulation? And if so, What Should be Changed?Denis Horgan, Barbara Moss, Stefania Boccia, et al.
European Journal of Human Genetics : EJHG|September 25, 2014
Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonablenessFranziska Severin, Pascal Borry, Martina C Cornel, et al.
Cancers|February 5, 2021
Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised MedicineDenis Horgan, Gennaro Ciliberto, Pierfranco Conte, et al.
Nature Genetics|April 11, 2018
Plain-language medical vocabulary for precision diagnosisNicole A Vasilevsky, Erin D Foster, Mark E Engelstad, et al.
Biomedicine Hub|February 10, 2021
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in OncologyDenis Horgan, Gennaro Ciliberto, Pierfranco Conte, et al.
Nature Reviews. Drug Discovery|March 2, 2010
Challenges with advanced therapy medicinal products and how to meet them, , Christian K Schneider, et al.
Nature|October 19, 2007
Genome-wide detection and characterization of positive selection in human populationsPardis C Sabeti, Patrick Varilly, Ben Fry, et al.
Nature|October 19, 2007
A second generation human haplotype map of over 3.1 million SNPs, Kelly A Frazer, Dennis G Ballinger, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Science Translational Medicine|July 7, 2017
Marketing of unproven stem cell-based interventions: A call to actionDouglas Sipp, Timothy Caulfield, Jane Kaye, et al.
European Journal of Human Genetics : EJHG|January 16, 2014
Managing clinically significant findings in research: the UK10K exampleJane Kaye, Matthew Hurles, Heather Griffin, et al.
Biomedicine Hub|February 10, 2021
Time for Change? The Why, What and How of Promoting Innovation to Tackle Rare Diseases - Is It Time to Update the EU's Orphan Regulation? And if so, What Should be Changed?Denis Horgan, Barbara Moss, Stefania Boccia, et al.
European Journal of Human Genetics : EJHG|September 25, 2014
Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonablenessFranziska Severin, Pascal Borry, Martina C Cornel, et al.
Cancers|February 5, 2021
Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised MedicineDenis Horgan, Gennaro Ciliberto, Pierfranco Conte, et al.
Nature Genetics|April 11, 2018
Plain-language medical vocabulary for precision diagnosisNicole A Vasilevsky, Erin D Foster, Mark E Engelstad, et al.
Biomedicine Hub|February 10, 2021
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in OncologyDenis Horgan, Gennaro Ciliberto, Pierfranco Conte, et al.
Nature Reviews. Drug Discovery|March 2, 2010
Challenges with advanced therapy medicinal products and how to meet them, , Christian K Schneider, et al.
Nature|October 19, 2007
Genome-wide detection and characterization of positive selection in human populationsPardis C Sabeti, Patrick Varilly, Ben Fry, et al.
Nature|October 19, 2007
A second generation human haplotype map of over 3.1 million SNPs, Kelly A Frazer, Dennis G Ballinger, et al.
Pageof 4